ChartMill assigns a Buy % Consensus number of 83% to CNTG. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-06-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-04-27 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-13 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-12 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-22 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-17 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-23 | HC Wainwright & Co. | Initiate | Buy |
| 2022-07-18 | SVB Leerink | Maintains | Outperform |
| 2021-06-17 | Credit Suisse | Maintains | Outperform |
7 analysts have analysed CNTG and the average price target is 1.53 USD. This implies a price increase of 370.77% is expected in the next year compared to the current price of 0.325.
The consensus rating for CENTOGENE NV (CNTG) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering CENTOGENE NV (CNTG) is 7.